Mitochondrial DNA (mtDNA) mutations can cause a wide range of severe diseases and are maternally inherited. Due to the lack of curative therapy, different strategies to prevent transmission of the mutation carrying mtDNA are being analyzed. One of these is the application of pronuclear transfer (PNT) to healthy cytoplasm.
Objective
Mitochondrial DNA (mtDNA) mutations can cause a wide range of severe diseases and are maternally inherited. Due to the lack of curative therapy, different strategies to prevent transmission of the mutation carrying mtDNA are being analyzed. One of these is the application of pronuclear transfer (PNT) to healthy cytoplasm.
Design
In this study, the potential of PNT was assessed in mice by measuring the mtDNA carry-over in pre-implantation embryos.
Materials and Methods
Pronuclei from zygotes of B6D2/F1 mouse were transplanted into enucleated NZB/OlaHsd mouse zygotes and vice versa to determine the quantity of mtDNA carried over in reconstructed zygotes as well as in individual blastomeres. The mtDNA carry-over was determined by restriction fragment length polymorphism (RFLP) analysis.
Results
Mean percentage of mtDNA carry-over in reconstructed zygotes and blastomeres was 1.26 (±1.83)% and 0.94 (±1.39)%, respectively. The carry-over range was similar in the reconstructed zygotes and blastomeres with a minimal carry-over of 0% and a maximal carryover of 4.47%. In 10 out of 17 samples, no mtDNA carry-over was detected (Table 1) . 
Conclusions
Our data show that there is almost no or minimal mtDNA carry-over after PNT. This technique could potentially be used to prevent transmission of mtDNA mutation disorders from mothers to their offspring, providing hope for diseased parents to fulfil their desire of conceiving healthy babies.
